Top Ten 2023: Drug Pricing and the Shift to Non-Institutional Care Settings
- February 24, 2023
Based on AHLA’s annual Health Law Connections article, this special series brings together thought leaders from across the health law field to discuss the top ten issues of 2023. In the eighth episode, Jane Jerzak, Principal, PYA, speaks with Todd Nova, Attorney, Hall Render Killian Heath & Lyman PC, about key developments related to drug pricing and regulation of the pharmaceutical delivery system. They discuss the effects of recent changes to the 340B program, the impacts of American Hospital Association v. Becerra and the Inflation Reduction Act, and how drug manufacturers and providers are reacting. Sponsored by PYA.
You must be logged in to access this content.